药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tazarotene
Bendamustine
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Bendamustine.
Tazarotene
Belatacept
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Belatacept.
Tazarotene
Golimumab
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Golimumab.
Tazarotene
Abetimus
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Abetimus.
Tazarotene
Bosutinib
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Bosutinib.
Tazarotene
Mepolizumab
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Mepolizumab.
Tazarotene
Panobinostat
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Panobinostat.
Tazarotene
Pazopanib
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Pazopanib.
Tazarotene
Rilonacept
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Rilonacept.
Tazarotene
Tocilizumab
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Tocilizumab.
Tazarotene
Canakinumab
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Canakinumab.
Tazarotene
Trastuzumab emtansine
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Trastuzumab emtansine.
Tazarotene
Apremilast
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Apremilast.
Tazarotene
Human interferon omega-1
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Human interferon omega-1.
Tazarotene
Briakinumab
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Briakinumab.
Tazarotene
Gallium nitrate
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Gallium nitrate.
Tazarotene
Glatiramer
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Glatiramer.
Tazarotene
Interferon alfa
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Interferon alfa.
Tazarotene
Trabectedin
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Trabectedin.
Tazarotene
Belinostat
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Belinostat.